Development and Maintenance of Thymic Epithelial Microenvironments
Development and Maintenance of Thymic Epithelial Microenvironments
批准号:
8527705
负责人:
MARK PEZZANO
金额:
$32.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-15 至 2016-07-31
关键词:
AddressAdipocytesAdultArchitectureAtrophicBiological ModelsBloodBone MarrowBone Marrow TransplantationCancer PatientCell CommunicationCell LineCell MaintenanceCell physiologyCell surfaceCellsCharacteristicsChondrocytesClinicalCoculture TechniquesDevelopmentDiseaseEngraftmentEpithelialExhibitsFluorescenceGene ExpressionGenesGenetically Engineered MouseGrowthHematological DiseaseHematopoiesisHematopoieticHematopoietic stem cellsHistonesHomeostasisHumanImmuneImmune systemIn VitroInfectionInjection of therapeutic agentIntegrinsKidneyLabelLeadLifeLocationMaintenanceMalignant - descriptorMalignant NeoplasmsMapsMesenchymalMesenchymal Stem CellsMinority-Serving InstitutionMorbidity - disease rateMouse StrainsNatural regenerationNon-MalignantNude MiceOperative Surgical ProceduresOsteoblastsPatientsPhenotypePopulationPopulation HeterogeneityProductivityPropertyProteinsPubertyPublicationsRecoveryRecruitment ActivityRelapseReporterResearchResearch PersonnelRoleSignal PathwaySignal TransductionSkinSorting - Cell MovementStem Cell FactorStem cell transplantStem cellsStructureStudentsT-Cell DevelopmentT-LymphocyteTACSTD2 geneTestingThymic TissueThymic epithelial cellThymus GlandTimeTissuesTrainingTransgenic MiceTransgenic ModelTranslationsTransplantationUnited States National Institutes of Healthadaptive immunityadult stem cellbasebonecancer therapycapsuledesignfightingfunctional lossimmune functionimprovedin vivoinhibitor/antagonistmouse modelnovelpluripotencypostnatalprematureprogenitorpublic health relevancereconstitutionresponseself-renewalstem cell populationtreatment strategy
中文摘要
说明(申请人提供):发展和维持一个功能正常的免疫系统有赖于一个组织和功能正常的胸腺。胸腺上皮细胞(TECs)构成胸腺的结构,负责维持胸腺的主要功能。骨髓移植可以治愈多种形式的血源性癌症以及非恶性血液疾病。不幸的是,尤其是在成年患者中,骨髓移植会损害胸腺,特别是TECs,导致抗击感染和癌症的能力降低。各种组织中的干细胞都是通过它们非常缓慢的分裂能力来鉴定的,即所谓的“标记保留细胞”(LRC)。一个
新型基因工程小鼠模型系统可用于鉴定和纯化活体组蛋白2B-绿色荧光蛋白标记的干细胞,并成功地用于鉴定和纯化皮肤干细胞,该系统已被用于纯化胸腺上皮干细胞。初步结果表明,外科手术将这些细胞转移到肾被膜下,可以形成功能性胸腺组织。这项研究的目的将是:1)进一步鉴定最近发现的具有改造胸腺组织的能力的胸腺上皮干细胞;2)了解控制成人胸腺干细胞维持的信号和细胞间的相互作用;3)在骨髓移植的小鼠模型中测试胸腺干细胞和最近开发的干细胞株的能力,以促进胸腺功能的恢复。这些研究将有助于设计新的临床策略,以对抗胸腺退化以及因癌症治疗和骨髓移植而发生的胸腺过早退化。从发展的角度来看,这项研究将允许PI继续培训服务不足的研究型学生,同时提高实验室的科学生产率和出版出版物的影响,使少数族裔服务机构的研究人员能够更有竞争力地获得NIH的支持。
英文摘要
DESCRIPTION (provided by applicant): Development and maintenance of a properly functioning immune system is dependent upon a properly organized and functioning thymus. Thymic epithelial cells (TECs) make up the structure of the thymus and are responsible for the maintaining its primary functions. Bone marrow transplants can cure many forms of blood-derived cancers as well as non-malignant blood disorders. Unfortunately, particularly in adult patients, bone marrow transplants damage the thymus and in particular TECs resulting in a reduced capacity to fight infection and cancer. Stem cells in a variety of tissues have been identified by their capacity to divide very slowly, the so-called "label retaining cells" (LRCs). A
novel genetically engineered mouse model system, which allows identification and purification of viable Histone 2B-green fluorescence protein tagged stem cells and was successfully used to identify and purify skin stem cells, has been used here to purify thymic epithelial stem cells. Preliminary results show that surgical transfer of these cells under the kidney capsule results in the formation of functional thymic tissue. The aims of this study will be to: 1) further characterie the recently identified thymic epithelial stem cells with the ability to reform thymic tissue; 2) understand the signals and cell to cell interactions that control the maintenance of adult thymic stem cells; 3) test the capacity of thymic stem cells and recently developed stem cell lines to enhance the recovery of thymic function in a mouse model of bone marrow transplant. These studies will be instrumental in the design of new clinical strategies to counteract thymic involution as well as the premature thymic degeneration that occurs in response to cancer treatments and BMT. From a developmental standpoint this study will allow the PI to continue to train underserved research students, while enhancing both the scientific productivity of the lab and the impact of the publications produced, enabling a researcher at a minority serving institution to be more competitive for NIH support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359238
-
项目类别:
-
资助金额:$4.19万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359286
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359244
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359285
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359283
-
项目类别:
-
资助金额:$54.19万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359284
-
项目类别:
-
资助金额:$3.69万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Development and Maintenance of Thymic Epithelial Microenvironments
-
批准号:8338776
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:MARK PEZZANO
-
依托单位:
Development and Maintenance of Thymic Epithelial Microenvironments
-
批准号:8697010
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2012
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:8357150
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2011
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7959167
-
项目类别:
-
资助金额:$36.24万
-
财政年份:2009
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:8166247
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2009
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:8091653
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7715273
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:7638658
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:7429263
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:7877928
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:8104282
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7561534
-
项目类别:
-
资助金额:$50.44万
-
财政年份:2007
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7336059
-
项目类别:
-
资助金额:$46.69万
-
财政年份:2006
-
负责人:MARK PEZZANO
-
依托单位:
TNC FUNCTION IN APOPTOTIC ANTIGEN DRIVEN AUTOIMMUNITY
-
批准号:7164332
-
项目类别:
-
资助金额:$10.12万
-
财政年份:2005
-
负责人:MARK PEZZANO
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: